Mechanical reperfusion for STEMI
Read Online

Mechanical reperfusion for STEMI from randomized trials to clinical practice

  • 254 Want to read
  • ·
  • 55 Currently reading

Published by Informa Healthcare USA in New York .
Written in English


  • Myocardial reperfusion,
  • Myocardial infarction -- Treatment,
  • Myocardial Reperfusion -- methods,
  • Myocardial Infarction -- surgery

Book details:

Edition Notes

Includes bibliographical references and index.

Statementedited by Giuseppe De Luca, Alexandra Lansky.
ContributionsDe Luca, Giuseppe, 1974-, Lansky, Alexandra.
LC ClassificationsRC685.I6 M43 2010
The Physical Object
Paginationp. ;
ID Numbers
Open LibraryOL24029084M
ISBN 101841846961
ISBN 109781841846965
LC Control Number2010001361

Download Mechanical reperfusion for STEMI


Mechanical Reperfusion for STEMI: From Randomized Trials to Clinical Practice - CRC Press Book As a leading cause of death in developed countries, ST-segment elevation myocardial infarction and its various treatment options are of great concern to those in the cardiology field. INTRODUCTION Several randomized trials and a pooled meta-analysis demonstrated the superiority of primary angioplasty as reperfusion therapy for ST-segment elevation myocardial infarction (STEMI) (1), confirmed even when transfer is needed (2), that is mostly explained by the higher rate of TIMI 3 flow achieved with mechanical : Giuseppe De Luca. Mechanical Reperfusion for STEMI Sign up to save your library With an OverDrive account, you can save your favorite libraries for at-a-glance information about availability. Find out more about OverDrive accounts. A truly outstanding book of STEMI. I am a current second year internal medicine resident and this is the book that I recommend for all the Internal medicine, Family medicine, Emergency medicine physicians,residents and medical students,especially for those interested in book explains STEMI in very comprehensive way, it has case scenario along with detail ECG interpretation /5(8).

As a leading cause of death in developed countries, ST-segment elevation myocardial infarction and its various treatment options are of great concern to those in the cardiology field. This text presents evidence-based chapters that supply clinicia.   A proposed algorithm retains emergent PCI for patients who are ‘high risk’ and those who fail reperfusion therapy. As with other aspects of life, continuing with business as usual for STEMI care in the COVID pandemic era may need to be reconsidered and FT may provide a . Although the optimal combination of fibrinolytics, antiplatelet agents, antithrombins, and mechanical reperfusion at hospitals with and without primary PCI facilities remains elusive, results from recent studies suggest that such a combined approach may facilitate transfer of patients with STEMI from a referral hospital to an invasive hospital for definitive primary PCI after administration of a potent pharmacologic regimen designed to enhance early infarct-related artery reperfusion. vessel occlusion that leads to STEMI •Fibrinolytic therapy was a major advance in the treatment of acute STEMI since >90% of STEMI is due to plaque rupture and subsequent thrombus formation •Remains a viable option for reperfusion therapy due to the limited availability of Primary PCI therapy.

It is a vital part of any pharmacological reperfusion strategy that potential reocclusion is actively considered and dealt with by “rescue” mechanical intervention. 4,5 However, irrespective of the apparent success of thrombolysis, good evidence is now emerging for predischarge angiogra19 and is a recommendation of the most recent Cited by: Summary. Reperfusion Therapy for Acute Myocardial Infarction provides a comprehensive review of reperfusion therapy for ST-segment elevation myocardial infarction (STEMI). Professor Eric R. Bates and his international team of contributors examine current and future reperfusion therapies for STEMI, in conjunction with the latest clinical trials and guidelines, to bring the most in-depth and. Time to Reperfusion and 6 Month Mortality In Low and High Risk Patients Florence, Italy Group 8 10 12 14 6 M o n t h M o r t a l i t y % % % % High Risk Antoniucci AJC ; 0 2 4 6 % % % % 0% Time to Reperfusion (hrs) 6 Low Risk. CCSAP Book 1 • Cardiology Critical Care 10 Antithrombotic Therapies in Acute Coronary Syndrome ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION Fibrinolysis Fibrinolysis was the initial reperfusion strategy for STEMI, which consisted of administering a fibrinolytic agent to.